GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.1706
+0.0106 (6.62%)
At close: Apr 28, 2025, 4:00 PM
0.1720
+0.0014 (0.82%)
After-hours: Apr 28, 2025, 7:44 PM EDT
GlucoTrack Employees
GlucoTrack had 11 employees as of December 31, 2024. The number of employees increased by 5 or 83.33% compared to the previous year.
Employees
11
Change (1Y)
5
Growth (1Y)
83.33%
Revenue / Employee
n/a
Profits / Employee
-$2,054,273
Market Cap
4.45M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
GCTK News
- 12 days ago - Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas - GlobeNewsWire
- 25 days ago - Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor - GlobeNewsWire
- 4 weeks ago - Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 5 weeks ago - Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes - GlobeNewsWire
- 2 months ago - Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member - GlobeNewsWire
- 2 months ago - Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering - GlobeNewsWire
- 2 months ago - Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor - GlobeNewsWire
- 3 months ago - Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer - GlobeNewsWire